SCHEMBL4669366

SCHEMBL4669366

CCOC(=O)C1=C(C)N=c2s/c(=C/c3ccc(OC(C)=O)cc3)c(=O)n2C1c1ccc(OC(C)=O)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN22 Q9Y2R2 5/20 0.74
MEN1 O00255 8/20 0.73
KMT2A Q03164 8/20 0.73
DUSP3 P51452 5/20 0.72
PTPN7 P35236 4/20 0.72
POLB P06746 3/20 0.72
PTPN12 Q05209 3/20 0.72
BLM P54132 2/20 0.72
CACNA1B Q00975 2/20 0.72
APBA1 Q02410 2/20 0.72
L3MBTL1 Q9Y468 2/20 0.72
DNMT1 P26358 1/20 0.72
ALDH1A1 P00352 3/20 0.71
SMN1; SMN2 Q16637 2/20 0.71
MAPT P10636 3/20 0.70
HPGD P15428 2/20 0.70
SAE1 Q9UBE0 1/20 0.70
UBA2 Q9UBT2 1/20 0.70
DUSP6 Q16828 1/20 0.70
CDC25B P30305 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4669368 1.00 PTPN22 (0.74) PTPN22MEN1KMT2ADUSP3PTPN7
SCHEMBL13855923 0.96 MEN1 (0.79) PTPN22MEN1KMT2ADUSP3PTPN7
SCHEMBL4669154 0.96 MEN1 (0.80) PTPN22MEN1KMT2ADUSP3PTPN7
SCHEMBL4669151 0.96 MEN1 (0.80) PTPN22MEN1KMT2ADUSP3PTPN7
SCHEMBL4669226 0.94 MAPT (0.68) PTPN22MEN1KMT2ADUSP3PTPN7
SCHEMBL4669224 0.94 MAPT (0.68) PTPN22MEN1KMT2ADUSP3PTPN7
SCHEMBL14104331 0.93 PTPN22 (0.66) PTPN22MEN1KMT2ADUSP3PTPN7
SCHEMBL4669378 0.91 ALDH1A1 (0.81) PTPN22MEN1KMT2ADUSP3PTPN7
SCHEMBL4669377 0.91 ALDH1A1 (0.81) PTPN22MEN1KMT2ADUSP3PTPN7
SCHEMBL4668142 0.90 CDC25B (0.85) PTPN22MEN1KMT2ADUSP3PTPN7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2000140-A1 Use of derivatives of 3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine or of 3-oxo-2,3-dihydro-5H-imidazolo[3,2-a]pyrimidine for the preparation of pharmaceutical compositions intended for the treatment of cancer INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2008-12-10 EP disclosed